Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Immunotherapy is a powerful developing therapy with the potential to impact all cancer types, changing the way cancer is treated and cured—forever.
Immunotherapy promises to change the lives of all people affected by cancer. Get to know the unique benefits of cancer immunotherapy below.
Immunotherapy is used to treat all cancers
Immunotherapy enables the immune system to recognize and target cancer cells, making it a universal answer to cancer.
Immunotherapy has been an effective treatment for patients with certain types of cancer that have been resistant to chemotherapy and radiation treatment (e.g., melanoma)
Immunotherapy side effects can be different from those seen with chemotherapy or radiation. They are usually related to stimulation of the immune system and can range from minor symptoms like rash, itching, and fever, to major conditions similar to autoimmune disorders and, in some rare cases, more severe side effects including death.
These side effects vary by type of cancer immunotherapy and each patient can respond differently. It is important when receiving treatment with immunotherapy to notify your doctor of any side effects, as many of these can be treated to prevent worsening.
Immunotherapy can “train” the immune system to remember cancer cells. This “immunomemory” may result in longer-lasting remissions.
Clinical studies on long-term overall survival have shown that the beneficial responses to cancer immunotherapy treatment are durable—that is, they can be maintained even after treatment is completed.
Cancer Immunotherapy works in two ways:
Create a profile and fill out a questionnaire to identify immunotherapy clinical trials you may be eligible for.
CALLING HOURS | M-F 8:30 a.m. to 6 p.m. ET
Se habla espanol
Request a call from a Clinical Trial Navigator
As a science-first organization dedicated to supporting cancer immunotherapy research, we're funding a future that fights back against cancer—all with your help.
Support others going through their journey with cancer immunotherapy treatment.
Read real stories of inspiration and lessons learned, or connect with our ImmunoAdvocates.
National Headquarters | One Exchange Plaza
55 Broadway, Suite 1802 | New York, NY 10006
(800) 992-2623(212) 832-9376Staff Directory
Atezolizumab’s third approval in the last year provides an important treatment option for a neglected population of patients with bladder cancer
TIME magazine honors Dr. Allison’s development of the first checkpoint immunotherapy, which has led to a revolution in cancer treatment.